{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T17:38:14Z","timestamp":1788025094726,"version":"build-2784847793"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2012,3,22]],"date-time":"2012-03-22T00:00:00Z","timestamp":1332374400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur Arch Otorhinolaryngol"],"published-print":{"date-parts":[[2013,1]]},"DOI":"10.1007\/s00405-012-1997-4","type":"journal-article","created":{"date-parts":[[2012,3,22]],"date-time":"2012-03-22T22:09:01Z","timestamp":1332454141000},"page":"281-285","source":"Crossref","is-referenced-by-count":33,"title":["Management and outcome of salivary duct carcinoma in major salivary glands"],"prefix":"10.1007","volume":"270","author":[{"given":"Elina","family":"Salovaara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olli","family":"Hakala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leif","family":"B\u00e4ck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petri","family":"Koivunen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kauko","family":"Saarilahti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabricio","family":"Passador-Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilmo","family":"Leivo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antti A.","family":"M\u00e4kitie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,3,22]]},"reference":[{"key":"1997_CR1","unstructured":"Finnish Cancer Registry, Cancer Society of Finland 2011. http:\/\/www.cancer.fi\/syoparekisteri\/en\/ . Accessed June 15th, 2011"},{"key":"1997_CR2","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1080\/00016480510003174","volume":"125","author":"H Luukkaa","year":"2005","unstructured":"Luukkaa H, Klemi P, Leivo I, Koivunen P, Laranne J, M\u00e4kitie A, Virtaniemi J, Hinkka S, Gr\u00e9nman R (2005) Salivary gland cancer in Finland 1991\u201396: an evaluation of 237 cases. Acta Otolaryngol 125:207\u2013214","journal-title":"Acta Otolaryngol"},{"key":"1997_CR3","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1007\/BF00301495","volume":"192","author":"O Kleinsasser","year":"1968","unstructured":"Kleinsasser O, Klein HJ, Hubner G (1968) Salivary duct carcinoma: a group of salivary gland tumors analogous to mammary duct carcinoma (German). Arch Klin Exp Ohren Nasen Kehlkopfheilkd 192:100\u2013105","journal-title":"Arch Klin Exp Ohren Nasen Kehlkopfheilkd"},{"key":"1997_CR4","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1136\/jcp.56.12.914","volume":"56","author":"A Etges","year":"2003","unstructured":"Etges A, Pinto DS Jr, Kowalski LP, Soares FA, Araujo VC (2003) Salivary duct carcinoma: immunohistochemical profile of an aggressive salivary gland tumour. J Clin Pathol 56:914\u2013918","journal-title":"J Clin Pathol"},{"key":"1997_CR5","first-page":"5675","volume":"54","author":"MF Press","year":"1994","unstructured":"Press MF, Pike MC, Hung G, Zhou JY, Ma Y, George J, Dietz-Band J, James W, Slamon DJ, Batsakis JG et al (1994) Amplification and overexpression of HER-2\/neu in carcinomas of the salivary gland: correlation with poor prognosis. Cancer Res 54:5675\u20135682","journal-title":"Cancer Res"},{"key":"1997_CR6","doi-asserted-by":"crossref","first-page":"2526","DOI":"10.1002\/cncr.21116","volume":"103","author":"M Jaehne","year":"2005","unstructured":"Jaehne M, Roeser K, Jaekel T, Schepers JD, Albert N, L\u00f6ning T (2005) Clinical and immunohistologic typing of salivary duct carcinoma: a report of 50 cases. Cancer 103:2526\u20132533","journal-title":"Cancer"},{"key":"1997_CR7","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1078\/0344-0338-00136","volume":"197","author":"A Sk\u00e1lov\u00e1","year":"2001","unstructured":"Sk\u00e1lov\u00e1 A, St\u00e1rek Kucerov\u00e1V, Sz\u00e9pe P, Plank L (2001) Salivary duct carcinoma\u2014a highly aggressive salivary gland tumor with HER-2\/neu oncoprotein overexpression. Pathol Res Pract 197:621\u2013626","journal-title":"Pathol Res Pract"},{"key":"1997_CR8","doi-asserted-by":"crossref","first-page":"2266","DOI":"10.1158\/1078-0432.CCR-09-0238","volume":"16","author":"MD Williams","year":"2010","unstructured":"Williams MD, Roberts DB, Kies MS, Mao L, Weber RS, El-Naggar AK (2010) Genetic and expression analysis of HER-2 and EGFR genes in salivary duct carcinoma: empirical and therapeutic significance. Clin Cancer Res 16:2266\u20132274","journal-title":"Clin Cancer Res"},{"key":"1997_CR9","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1002\/hed.20714","volume":"30","author":"A Prat","year":"2008","unstructured":"Prat A, Parera M, Reyes V, Peralta S, Cedr\u00e9s S, Andreu J, Huguet P, del Campo JM (2008) Successful treatment of pulmonary metastatic salivary ductal carcinoma with trastuzumab-based therapy. Head Neck 30:680\u2013683","journal-title":"Head Neck"},{"key":"1997_CR10","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1002\/hed.20614","volume":"29","author":"V Nabili","year":"2007","unstructured":"Nabili V, Tan JW, Bhuta S, Sercarz JA, Head CS (2007) Salivary duct carcinoma: a clinical and histologic review with implications for trastuzumab therapy. Head Neck 29:907\u2013912","journal-title":"Head Neck"},{"key":"1997_CR11","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1017\/S0022215108002314","volume":"123","author":"M Nashed","year":"2009","unstructured":"Nashed M, Casasola RJ (2009) Biological therapy of salivary duct carcinoma. J Laryngol Otol 123:250\u2013252","journal-title":"J Laryngol Otol"},{"key":"1997_CR12","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1002\/(SICI)1097-0142(19960115)77:2<223::AID-CNCR1>3.0.CO;2-N","volume":"77","author":"JE Lewis","year":"1996","unstructured":"Lewis JE, McKinney BC, Weiland LH, Ferreiro JA, Olsen KD (1996) Salivary duct carcinoma. Clinicopathologic and immunohistochemical review of 26 cases. Cancer 77:223\u2013230","journal-title":"Cancer"},{"key":"1997_CR13","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/S0194-5998(03)01386-X","volume":"129","author":"AS Hosal","year":"2003","unstructured":"Hosal AS, Fan C, Barnes L, Myers EN (2003) Salivary duct carcinoma. Otolaryngol Head Neck Surg 129:720\u2013725","journal-title":"Otolaryngol Head Neck Surg"},{"key":"1997_CR14","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1002\/(SICI)1097-0347(199703)19:2<126::AID-HED7>3.0.CO;2-6","volume":"19","author":"M Guzzo","year":"1997","unstructured":"Guzzo M, Di Palma S, Grandi C, Molinari R (1997) Salivary duct carcinoma: clinical characteristics and treatment strategies. Head Neck 19:126\u2013133","journal-title":"Head Neck"},{"key":"1997_CR15","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1002\/cncr.9050","volume":"93","author":"T Moriki","year":"2001","unstructured":"Moriki T, Ueta S, Takahashi T, Mitani M, Ichien M (2001) Salivary duct carcinoma: cytologic characteristics and application of androgen receptor immunostaining for diagnosis. Cancer 93:344\u2013350","journal-title":"Cancer"},{"key":"1997_CR16","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1002\/1097-0142(19930901)72:5<1503::AID-CNCR2820720503>3.0.CO;2-K","volume":"72","author":"R Delgado","year":"1993","unstructured":"Delgado R, Vuitch F, Albores-Saavedra J (1993) Salivary duct carcinoma. Cancer 72:1503\u20131512","journal-title":"Cancer"},{"key":"1997_CR17","first-page":"1033","volume":"11","author":"SB Kapadia","year":"1998","unstructured":"Kapadia SB, Barnes L (1998) Expression of androgen receptor, gross cystic disease fluid protein, and CD44 in salivary duct carcinoma. Mod Pathol 11:1033\u20131038","journal-title":"Mod Pathol"},{"key":"1997_CR18","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1097\/00000478-200004000-00014","volume":"24","author":"CY Fan","year":"2000","unstructured":"Fan CY, Wang J, Barnes EL (2000) Expression of androgen receptor and prostatic specific markers in salivary duct carcinoma: an immunohistological analysis of 13 cases and review of the literature. Am J Surg Pathol 24:579\u2013586","journal-title":"Am J Surg Pathol"},{"key":"1997_CR19","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1097\/PAS.0b013e3180caa099","volume":"31","author":"MD Williams","year":"2007","unstructured":"Williams MD, Roberts DE, Blumenschein GR, Temam S, Kies MS, Rosenthal DI, Weber RS, El-Naggar AK (2007) Differential expression of hormonal and growth factor receptors in salivary duct carcinomas: biologic significance and potential role in therapeutic stratification of patients. Am J Surg Pathol 31:1645\u20131652","journal-title":"Am J Surg Pathol"},{"key":"1997_CR20","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1200\/JCO.2010.32.8351","volume":"29","author":"HC Jaspers","year":"2011","unstructured":"Jaspers HC, Verbist BM, Schoffelen R, Mattijssen V, Slootweg PJ, van der Graaf WT, van Herpen CM (2011) Androgen receptor-positive salivary duct carcinoma: a disease entity with promising new treatment options. J Clin Oncol 29:473\u2013476","journal-title":"J Clin Oncol"},{"key":"1997_CR21","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1093\/annonc\/mdg331","volume":"14","author":"LD Locati","year":"2003","unstructured":"Locati LD, Quattrone P, Bossi P, Marchian\u00f2 AV, Cant\u00f9 G, Licitra L (2003) A complete remission with androgen-deprivation therapy in a recurrent androgen receptor-expressing adenocarcinoma of the parotid gland. Ann Oncol 14:1327\u20131328","journal-title":"Ann Oncol"},{"key":"1997_CR22","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/S0046-8177(96)90162-8","volume":"27","author":"A Felix","year":"1996","unstructured":"Felix A, El-Naggar AK, Press MF, Ordonez NG, Fonseca I, Tucker SL, Luna MA, Batsakis JG (1996) Prognostic significance of biomarkers (c-erbB-2, p53, proliferating cell nuclear antigen, and DNA content) in salivary duct carcinoma. Hum Pathol 27:561\u2013566","journal-title":"Hum Pathol"},{"key":"1997_CR23","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1002\/jso.21045","volume":"97","author":"JL Roh","year":"2008","unstructured":"Roh JL, Cho KJ, Kwon GY, Choi SH, Nam SY, Kim SY (2008) Prognostic values of pathologic findings and hypoxia markers in 21 patients with salivary duct carcinoma. J Surg Oncol 97:596\u2013600","journal-title":"J Surg Oncol"},{"key":"1997_CR24","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1002\/hed.21444","volume":"33","author":"TM Feinstein","year":"2011","unstructured":"Feinstein TM, Lai SY, Lenzner D, Gooding W, Ferris RL, Grandis JR, Myers EN, Johnson JT, Heron DE, Argiris A (2011) Prognostic factors in patients with high-risk locally advanced salivary gland cancers treated with surgery and postoperative radiotherapy. Head Neck 33:318\u2013323","journal-title":"Head Neck"},{"key":"1997_CR25","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1097\/CCO.0b013e328344f59c","volume":"23","author":"DJ Adelstein","year":"2011","unstructured":"Adelstein DJ, Rodriguez CP (2011) What is new in the management of salivary gland cancers? Curr Opin Oncol 23:249\u2013253","journal-title":"Curr Opin Oncol"},{"key":"1997_CR26","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1001\/archotol.133.10.1031","volume":"133","author":"G Cornolti","year":"2007","unstructured":"Cornolti G, Ungari M, Morassi ML, Facchetti F, Rossi E, Lombardi D, Nicolai P (2007) Amplification and overexpression of HER2\/neu gene and HER2\/neu protein in salivary duct carcinoma of the parotid gland. Arch Otolaryngol Head Neck Surg 133:1031\u20131036","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"1997_CR27","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/j.oraloncology.2006.12.012","volume":"43","author":"A Milano","year":"2007","unstructured":"Milano A, Longo F, Basile M, Iaffaioli RV, Caponigro F (2007) Recent advances in the treatment of salivary gland cancers: emphasis on molecular targeted therapy. Oral Oncol 43:729\u2013734","journal-title":"Oral Oncol"}],"container-title":["European Archives of Oto-Rhino-Laryngology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00405-012-1997-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00405-012-1997-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00405-012-1997-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,21]],"date-time":"2024-04-21T21:34:32Z","timestamp":1713735272000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00405-012-1997-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3,22]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,1]]}},"alternative-id":["1997"],"URL":"https:\/\/doi.org\/10.1007\/s00405-012-1997-4","relation":{},"ISSN":["0937-4477","1434-4726"],"issn-type":[{"value":"0937-4477","type":"print"},{"value":"1434-4726","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,3,22]]}}}